Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor
NQF is the FDA product code for Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor, a class III device type, regulated under 21 CFR 864.1860. FDA's definition for this code reads: "The epidermal growth factor receptor (EGFR) antibody/assay is a qualitative immunohistochemical antibody/assay to identify EGFR expression in normal and neoplastic tissues routinely-fixed for histological evaluation. EGFR antibody/assay specifically detects the EGFR (HER1) protein in EGFR-expressing cells. This...". As of , FDA records hold no 510(k) clearances under this code and no recalls.
Classification record
- Product code
- NQF
- Device name
- Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor
- FDA definition
- The epidermal growth factor receptor (EGFR) antibody/assay is a qualitative immunohistochemical antibody/assay to identify EGFR expression in normal and neoplastic tissues routinely-fixed for histological evaluation. EGFR antibody/assay specifically detects the EGFR (HER1) protein in EGFR-expressing cells. This antibody/assay is indicated as an aid in identifying colorectal cancer patients eligible for treatment with cetuximab, a monoclonal antibody drug. This will be a specialized subcategory for EGFR immunohistochemistry assays under the general heading of the regulation for all Immunohistochemistry assays.
- Regulation
- 21 CFR 864.1860
- Device class
- Class III
- Review panel
- Hematology
- Submission type
- PMA
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 0
- Ingested recalls
- 0
Companies listing this code with FDA
Companies whose registered establishments list this codeNo registered establishment in MDM’s records lists product code NQF.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
